Recent News:
2022
2020
New progress in the development of treatments for patients diagnosed with triple negative breast cancer
- • Alternatives for triple negative breast cancer
- • Nature Communications - GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Lab Affiliations:
Princess Margaret Cancer Centre
![]() |
Structural Genomics Consortium
![]() |
University of Toronto![]() |
Funding:
Terry Fox Foundation
![]() |
Huntington Society Canada![]() |
Lymphoma Leukemia Society
![]() |
Canada Institutes of Health Research
![]() |
NSERC![]() |
SU2C
![]() |
Lab Members Online:
Rachel Harding
![]() |
Open Lab Notebooks![]() |
Collaborators:
Penn Lab
![]() |
Raught Lab
![]() |
Lupien Lab
![]() |